Introduction
Continuous ambulatory peritoneal dialysis (CAPD) is an
important treatment option for patients who are at the end
stage of renal disease. Although the rate of peritonitis has
declined in recent years because of improvements in the
CAPD technique, peritonitis remains the leading cause for
discontinuation of CAPD [1].
Sphingomonas paucimobilis is frequently isolated from
environmental sources such as soil and water, and it is found
on hospital equipment such as ventilators, nebulizers, and
humidifiers [2,3]. Although S. paucimobilis plays an extremely
limited role as an infectious agent [4], it is responsible for two
types of human infections: community-acquired infection and
nosocomial infection [5]. Cases of peritonitis by S. paucimobilis
have been reported rarely. The clinical outcomes were diverse
in previously reported peritoneal dialysis (PD)-associated
peritonitis cases [2,5–7]. Furthermore, definitive guidelines
do not exist for treating S. paucimobilis.
Introduction
Continuous ambulatory peritoneal dialysis (CAPD) is an
important treatment option for patients who are at the end
stage of renal disease. Although the rate of peritonitis has
declined in recent years because of improvements in the
CAPD technique, peritonitis remains the leading cause for
discontinuation of CAPD [1].
Sphingomonas paucimobilis is frequently isolated from
environmental sources such as soil and water, and it is found
on hospital equipment such as ventilators, nebulizers, and
humidifiers [2,3]. Although S. paucimobilis plays an extremely
limited role as an infectious agent [4], it is responsible for two
types of human infections: community-acquired infection and
nosocomial infection [5]. Cases of peritonitis by S. paucimobilis
have been reported rarely. The clinical outcomes were diverse
in previously reported peritoneal dialysis (PD)-associated
peritonitis cases [2,5–7]. Furthermore, definitive guidelines
do not exist for treating S. paucimobilis.
การแปล กรุณารอสักครู่..
